| Affiliation: | 1. Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA;2. Meyer Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA;2. Research Division, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne;3. Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia;1. Molecular and Cell Biology Laboratory, Dulbecco Center for Cancer Research, Salk Institute for Biological Studies, La Jolla, CA 92037, USA;2. Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA;1. Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, P.O. Box 6128, Station Centre-ville, Montréal Québec, H3C 3J7 , Canada;2. Department of Chemistry, Faculty of Arts and Sciences, Université de Montréal, P.O. Box 6128, Station Centre-ville, Montréal Québec, H3C 3J7 , Canada;3. Institute for Research in Immunology and Cancer, Université de Montréal, P.O. Box 6128, Station Centre-ville, Montréal Québec, H3C 3J7 , Canada;1. Department of Pathology and Oncology, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan;2. Respiratory Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan;3. Division of Manufacturing, Research and Development, Immuno-Biological Laboratories Co., Ltd, 1091-1 Naka, Fujioka-Shi, Gunma 375-0005, Japan;4. Research Administration, Dainippon Sumitomo Pharma Co., Ltd, 33-94 Enoki-Cho, Suita, Osaka 564-0053, Japan;5. Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd, 3-1-98, Kasugade-Naka, Konohana-Ku, Osaka 554-0022, Japan |
